Abbott (ABT) Tops Q1 EPS by 2c, Offers Guidance

Abbott (NYSE: ABT) reported Q1 EPS of $1.09, $0.02 better than the analyst estimate of $1.07. Revenue for the quarter came in at $10.36 billion versus the consensus estimate of $10.4 billion.

GUIDANCE:

Abbott sees Q2 2025 EPS of $1.23-$1.27, versus the consensus of $1.25.

Abbott sees FY2025 EPS of $5.05-$5.25, versus the consensus of $5.15.

• Abbott projects full-year 2025 organic sales growth to be in the range of 7.5% to 8.5%.
• Abbott projects full-year 2025 adjusted operating margin to be 23.5% to 24.0% of sales.
• Abbott projects full-year 2025 adjusted diluted earnings per share of $5.05 to $5.25 and second-quarter 2025 adjusted diluted earnings per share of $1.23 to $1.27.

For earnings history and earnings-related data on Abbott (ABT) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• A.O. Smith executive chairman to retire, CEO to assume chairman role
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval